Compare Matahari Putra Prima Tbk. (MPPA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Matahari Putra Prima Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Matahari Putra Prima Tbk. trades at Rp42 (market cap 1.39T, 4.04M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Matahari Putra Prima Tbk. is far larger — about 13.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MPPA | SCPI | |
|---|---|---|
Market Cap | 1.39T | 104.4B |
Volume | 4.04M | — |
Lot | 40.4K | — |
Turnover | 169.68M | — |
Average Price | 42 | — |
Value | 169.68M | — |
Indicative Equilibrium Price | 42 | — |
Indicative Equilibrium Volume | 7.43K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Matahari Putra Prima Tbk.
PT. Matahari Putra Prima Tbk was established on March 11, 1986. The company’s head office is located at Menara Matahari – Lippo Karawaci. As of December 31, 2000, the company and a subsidiary ( PT Matahari Super Ekonomi ) operate all of the 77 stores known as Matahari Department Store, Galeria Matahari, Mega M, Super Ekonomi and Super Bazaar located in Jakarta and other cities in Indonesia.
Read more on MPPA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
